United States · FDA National Drug Code directory
Lithium Carbonate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 62756-430_b0888aa2-be9d-4a45-81b2-a59493bc4892
- Product NDC
- 62756-430
- Form
- TABLET
- Composition / generic term
- Lithium Carbonate
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100708
- Source listing expiry
- 20261231
Source-listed ingredients
- LITHIUM CARBONATE — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET in 1 BOTTLE (62756-430-08) · 62756-430-08
- 1000 TABLET in 1 BOTTLE (62756-430-18) · 62756-430-18
- 30 TABLET in 1 BOTTLE (62756-430-83) · 62756-430-83
- 100 TABLET in 1 BOTTLE (62756-430-88) · 62756-430-88
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →